Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 8/2020

01-08-2020 | Vaccination | Viewpoint

COVID-19 and Health Disparities: the Reality of “the Great Equalizer”

Author: Stephen A Mein, MD

Published in: Journal of General Internal Medicine | Issue 8/2020

Login to get access

Excerpt

From government officials to mainstream media and even celebrities, coronavirus disease 2019 (COVID-19) has been touted as “the great equalizer.” It is a disease that transcends wealth, fame, prestige, or age. We are all at risk. The statement highlights our vulnerability as part of a society that lacks any immunity to the novel virus. However, it also inaccurately assumes that we will all be equally affected by it. History has shown that this will not be the case. …
Literature
1.
2.
Hutchins SS, Fiscella K, Levine RS, et al. Protection of racial/ethnic minority populations during an influenza pandemic. Am J Public Health. 2009 Oct;99 Suppl 2:S261-70.CrossRef
3.
4.
5.
Quinn SC, Kumar S, Freimuth VS, et al. Racial disparities in exposure, susceptibility, and access to health care in the US H1N1 influenza pandemic. Am J Public Health. 2011 Feb;101(2):285-93.CrossRef
6.
Blumenshine P, Reingold A, Egerter S, et al. Pandemic influenza planning in the United States from a health disparities perspective. Emerg Infect Dis. 2008 May;14(5):709-15.CrossRef
7.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062.CrossRef
Metadata
Title
COVID-19 and Health Disparities: the Reality of “the Great Equalizer”
Author
Stephen A Mein, MD
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 8/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05880-5

Other articles of this Issue 8/2020

Journal of General Internal Medicine 8/2020 Go to the issue

Exercises in Clinical Reasoning

The Writing on the Wall: An Exercise in Clinical Reasoning

Perspective

Health Literacy 2030: Is It Time to Redefine the Term?

Viewpoint

Health Disparities and the Coronavirus Disease 2019 (COVID-19) Pandemic in the USA

Letter to the Editor

Differences in Breast Density Awareness, Knowledge, and Plans

Original Research

Effect of the Patient-Centered Medical Home on Racial Disparities in Quality of Care

Original Research

Association of Glycemic Control Trajectory with Short-Term Mortality in Diabetes Patients with High Cardiovascular Risk: a Joint Latent Class Modeling Study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits